Similar to the case with effects on FAK activity derived from CAP1 depletion, opposite effects on ERK activity were detected in the metastatic and non-metastatic breast cancer cells, where elevated ERK activity in the metastatic breast cancer cells was detected along with activated FAK. The gene discussed is PTK2; the disease is breast carcinoma.